$0.01
(Market cap
$23 Mln
Revenue (TTM)
$86 Mln
P/E Ratio
--
P/B Ratio
2.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.5 %
-
ROCE
-- %
-
Industry P/E
43.99
-
EV/EBITDA
42.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.2
-
Face value
--
-
Shares outstanding
4,510,182
10 Years Aggregate
CFO
$47.66 Mln
EBITDA
$41.92 Mln
Net Profit
$-51.03 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Harvard Bioscience (HBIO)
| -19.1 | -22.6 | -7.3 | 60.8 | -54.5 | -40.1 | -16.5 |
|
BSE Sensex
| -11.2 | -4.2 | -9.2 | -7.4 | 6.8 | 8.7 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Harvard Bioscience (HBIO)
| -68.3 | -60.3 | 93.1 | -60.7 | 64.3 | 40.7 | -4.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Harvard Bioscience (HBIO)
|
5.4 | 22.6 | 85.5 | -9.8 | -2.9 | -81.1 | -- | 2.4 |
| 7.9 | 5,216.3 | 6,552.2 | -551.4 | -4.3 | -9.9 | -- | 1.0 | |
| 267.4 | 7,156.9 | 2,589.9 | 168.8 | 21.4 | 2.5 | 44.4 | 1.0 | |
| 44.6 | 6,483.3 | 3,458.5 | -11.6 | 2.6 | -0.5 | -- | 2.7 | |
| 23.4 | 3,750.9 | 2,808.1 | 67.7 | 6.8 | 2.2 | 56.2 | 1.2 | |
| 139.7 | 8,216.9 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 12.2 | |
| 95.0 | 6,047.7 | 1,546.2 | 279.0 | 15.0 | 23.9 | 22.2 | 5.0 | |
| 178.8 | 9,363.6 | 1,558.5 | 76.3 | 19.6 | 9.5 | 44.3 | 11.8 | |
| 326.9 | 12,843.7 | 1,454.3 | 171.1 | 11.1 | 12.1 | 75.2 | 8.7 | |
| 112.4 | 6,121.4 | 763.3 | 51.4 | 11.7 | 2.5 | 119.3 | 2.8 |
Shareholding Pattern
View DetailsAbout Harvard Bioscience (HBIO)
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular... technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts. Address: 84 October Hill Road, Holliston, MA, United States, 01746 Read more
-
President, CEO & Chairman
Mr. James W. Green
-
President, CEO & Chairman
Mr. James W. Green
-
Headquarters
Holliston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Harvard Bioscience (HBIO)
What is the current share price of Harvard Bioscience Inc (HBIO) Today?
The share price of Harvard Bioscience Inc (HBIO) is $5.41 (NASDAQ) as of 21-May-2026 11:25 EDT. Harvard Bioscience Inc (HBIO) has given a return of -54.52% in the last 3 years.
What is the current PB & PE ratio of Harvard Bioscience Inc (HBIO)?
Since, TTM earnings of Harvard Bioscience Inc (HBIO) is negative, P/E ratio is not available.
The P/B ratio of Harvard Bioscience Inc (HBIO) is 2.41 times as on 20-May-2026, a 17 discount to its peers’ median range of 2.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.05
|
0.22
|
|
2024
|
-0.74
|
0.15
|
|
2023
|
-6.69
|
0.31
|
|
2022
|
-1.23
|
0.16
|
|
2021
|
-106.17
|
0.37
|
What is the 52 Week High and Low of Harvard Bioscience Inc (HBIO)?
The 52-week high and low of Harvard Bioscience Inc (HBIO) are Rs 9.46 and Rs 2.81 as of 21-May-2026.
What is the market cap of Harvard Bioscience Inc (HBIO)?
Harvard Bioscience Inc (HBIO) has a market capitalisation of $ 23 Mln as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Harvard Bioscience Inc (HBIO)?
Before investing in Harvard Bioscience Inc (HBIO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.